Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Elliot M Antman"'
Autor:
Siddharth M Patel, Michael G Palazzolo, Sabina A Murphy, Elliot M Antman, Eugene Braunwald, Hans-Joachim Lanz, Gregory Y H Lip, Robert P Giugliano, Christian T Ruff
Publikováno v:
Patel, S M, Palazzolo, M G, Murphy, S A, Antman, E M, Braunwald, E, Lanz, H J, Lip, G Y H, Giugliano, R P & Ruff, C T 2022, ' Evaluation of the atrial fibrillation better care pathway in the ENGAGE AF-TIMI 48 trial ', Europace, vol. 24, no. 11, pp. 1730-1738 . https://doi.org/10.1093/europace/euac082
Aims The Atrial fibrillation Better Care (ABC) pathway is endorsed by guidelines to improve care of patients with atrial fibrillation (AF). However, whether the benefit of ABC pathway-concordant care is consistent across anticoagulants remains unclea
Autor:
David A. Morrow, Elliot M Antman, H Lanz, Sabina A. Murphy, Minao Tang, David D. Berg, Kazuma Oyama, Michael A. Grosso, Christian T. Ruff, E Braunwald, Robert P. Giugliano
Publikováno v:
European Heart Journal. 41
Background Patients with atrial fibrillation (AF) have progressive cardiac structural changes that may be manifest by biomarkers of myocardial injury and hemodynamic stress. Baseline values of hsTnT (high-sensitivity troponin T), and NT-proBNP (N-ter
Autor:
Jeong-Gun Park, E Braunwald, Elliot M Antman, Sabina A. Murphy, Christian T. Ruff, Robert P. Giugliano, Jan Steffel
Publikováno v:
European Heart Journal. 41
Background In the phase 3 RCT ENGAGE AF-TIMI 48, both the higher-dose (HDER/edoxaban 60/30mg) and lower-dose edoxaban regimen (LDER/edoxaban 30/15mg) were non-inferior to well-managed warfarin for the prevention of stroke or systemic embolic events i
Autor:
Megan L. Neely, Sonia Huang, Lars Wallentin, Michelle T. Sun, Christopher X. Wong, Elliot M Antman, E. Magnus Ohman, Matthew T. Roe, Stephen D. Wiviott
Publikováno v:
The American journal of cardiology. 125(8)
Intraocular bleeding is a devastating clinical event due to its potentially blinding nature. It is not known if determine if dual antiplatelet therapy using aspirin and potent P2Y12 inhibitors increases this risk. We searched MEDLINE and ClinicalTria
Autor:
Christian T. Ruff, Robert P. Giugliano, Howard Rutman, Elliot M Antman, Scott D. Solomon, E Braunwald, Riccardo M. Inciardi, Francesco Nordio
Publikováno v:
European Heart Journal. 40
Introduction Atrial Fibrillation (AF) is associated with increased risk of cardiovascular (CV) morbidity and mortality. Heart Failure (HF) represents the most common CV complication, more common than thromboembolic events. Purpose We aimed to determi
Autor:
E Braunwald, Julia F Kuder, Christian T. Ruff, G Boriani, Robert P. Giugliano, Minggao Shi, Elliot M Antman, H Lanz
Publikováno v:
European Heart Journal. 40
Background The impact on outcomes of oral anticoagulants in pts at extremes of body weight have not been well-characterized. Aim To analyse the outcomes of pts with atrial fibrillation (AF) enrolled in ENGAGE AF-TMI 48 randomized to warfarin (W) targ
Autor:
Howard Rutman, R. De Caterina, H Lanz, E Braunwald, Michele Mercuri, Rose A. Hamershock, Sabina A. Murphy, Christian T. Ruff, Robert P. Giugliano, Elliot M Antman
Publikováno v:
European Heart Journal. 39
Autor:
Jan Steffel, Christian T. Ruff, Sabina A. Murphy, Elliot M Antman, Robert P. Giugliano, Markku S. Nieminen, H Lanz, M Mercury, Rose A. Hamershock, E Braunwald, Nancy Peterson
Publikováno v:
European Heart Journal. 39
Autor:
Sidney C. Smith, Robert E. Suter, Gregg C. Fonarow, Ileana L. Piña, Kathryn A. Taubert, Louise Morgan, Elliot M Antman, Eduardo Sanchez
Publikováno v:
Revista Española de Cardiología. 68:924-927
Autor:
Tze-Fan Chao, Christian T. Ruff, Michele Mercuri, Robert P. Giugliano, Rose A. Hamershock, Christina L. Fanola, Elliot M Antman, S.A Chen, E Braunwald
Publikováno v:
European Heart Journal. 38